
Ceres Power Holdings PLC — Investor Relations & Filings
Ceres Power is a developer of clean energy technology centered on its proprietary solid oxide platform. The company operates an asset-light licensing model, providing its solid oxide fuel cell (SOFC) and solid oxide electrolyzer cell (SOEC) technologies to global manufacturing partners. The SOFC technology enables highly efficient, fuel-flexible power generation for applications in data centers, commercial power, and industry. The SOEC technology is designed for the production of low-cost green hydrogen, a critical component for decarbonizing industrial processes, transportation, and creating green fuels like ammonia. Ceres collaborates with multinational corporations to embed its technology into their products, facilitating scalable deployment to address climate change.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-06-01 | English | |
| Total Voting Rights | 2026-05-29 | English | |
| Special Resolutions passed at the 2026 AGM | 2026-05-15 | English | |
| Directorate change | 2026-05-14 | English | |
| Result of AGM | 2026-05-14 | English | |
| Group of companies' accounts made up to 2025-12-31 | 2026-05-09 | English |
Browse filings by year
19 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47920395 | Holding(s) in Company | 2026-06-01 | English | ||
| 47881490 | Total Voting Rights | 2026-05-29 | English | ||
| 46352877 | Special Resolutions passed at the 2026 AGM | 2026-05-15 | English | ||
| 46076181 | Directorate change | 2026-05-14 | English | ||
| 46076178 | Result of AGM | 2026-05-14 | English | ||
| 46821417 | Group of companies' accounts made up to 2025-12-31 | 2026-05-09 | English | ||
| 44292452 | Holding(s) in Company | 2026-05-08 | English | ||
| 44292442 | Grant of Share Options under the Sharesave Scheme | 2026-05-08 | English | ||
| 44185156 | Holding(s) in Company | 2026-05-08 | English | ||
| 41762069 | Holding(s) in Company | 2026-05-06 | English | ||
| 41333836 | Holding(s) in Company | 2026-05-05 | English | ||
| 39496111 | Director/PDMR Shareholding | 2026-05-01 | English | ||
| 39447704 | Holding(s) in Company | 2026-05-01 | English | ||
| 39084694 | Holding(s) in Company | 2026-04-30 | English | ||
| 39084693 | Holding(s) in Company | 2026-04-30 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Ceres Power Holdings PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
Ceres Power Holdings PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/6312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=6312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=6312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=6312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 6312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ceres Power Holdings PLC (id: 6312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.